ÔªøChronic Transplantation of Olfactory Ensheathing Cells	1
ÔªøChronic Transplantation	1
Olfactory Ensheathing Cells	31
Partial Recovery	68
Complete Spinal Cord Transection in the Rat RUBE`N L OPEZ-VALES ,1 JOAQUIM FOR ES ,1,2 XAVIER NAVARRO ,1 AND ENRIQUE VERD U1 * 1Group of Neuroplasticity and Regeneration , Institute of Neuroscience and Department of Cell Biology , Physiology and Immunology , Universitat Auto ` noma de Barcelona , Bellaterra , Spain 2Hand and Peripheral Nerve Unit	91
Complete Spinal Cord Transection	91
the Rat RUBE`N L OPEZ-VALES ,1 JOAQUIM FOR ES ,1,2 XAVIER NAVARRO ,1 AND ENRIQUE VERD U1 * 1Group of Neuroplasticity and Regeneration , Institute of Neuroscience and Department of Cell Biology , Physiology and Immunology , Universitat Auto	127
the Rat RUBE`N L OPEZ-VALES ,1 JOAQUIM FOR ES ,1,2 XAVIER NAVARRO ,1 AND ENRIQUE VERD U1 * 1Group of Neuroplasticity and Regeneration	127
the Rat RUBE`N L	127
OPEZ-VALES ,1 JOAQUIM FOR ES ,1,2 XAVIER NAVARRO ,1 AND ENRIQUE VERD U1 * 1Group of Neuroplasticity and Regeneration	145
OPEZ-VALES ,1 JOAQUIM	145
ES ,1,2 XAVIER NAVARRO ,1 AND ENRIQUE VERD U1	170
ES ,1,2 XAVIER NAVARRO	170
,1 AND ENRIQUE VERD U1	191
,1	191
ENRIQUE VERD U1	198
1Group of Neuroplasticity and Regeneration	215
1Group	215
Neuroplasticity and Regeneration	225
Institute of Neuroscience and Department of Cell Biology , Physiology	259
Institute	259
Neuroscience and Department	272
Cell Biology , Physiology	303
Immunology , Universitat Auto	332
Immunology	332
Universitat Auto	344
noma de Barcelona	361
Bellaterra	380
Spain 2Hand	392
Peripheral Nerve Unit	408
Hospital Cl	431
± nic i Provincial , Universitat de Barcelona , Barcelona , Spain ABSTRACT The goal of this study was to ascertain whether olfactory ensheathing cells -LRB- OECs -RRB- were able to promote axonal regeneration and functional recovery when transplanted 45 days after complete transection of the thoracic spinal cord in adult rats	444
± nic i	444
Provincial , Universitat de Barcelona , Barcelona , Spain ABSTRACT The goal of this study was to ascertain whether olfactory ensheathing cells -LRB- OECs -RRB- were able to promote axonal regeneration and functional recovery when transplanted 45 days after complete transection of the thoracic spinal cord in adult rats	451
Provincial , Universitat de Barcelona	451
Barcelona	489
Spain ABSTRACT The goal of this study was to ascertain whether olfactory ensheathing cells -LRB- OECs -RRB- were able to promote axonal regeneration and functional recovery when transplanted 45 days after complete transection of the thoracic spinal cord in adult rats	500
Spain ABSTRACT	500
The goal of this study	516
The goal	516
this study	528
olfactory ensheathing cells -LRB- OECs -RRB-	564
olfactory ensheathing cells	564
OECs	593
axonal regeneration and functional recovery	620
regeneration	627
45 days	682
complete transection of the thoracic spinal cord in adult rats	696
complete transection	696
the thoracic spinal cord in adult rats	720
the thoracic spinal cord	720
adult rats	748
OECs	760
partial restitution of supraspinal pathways evaluated by motor	774
partial restitution	774
supraspinal pathways evaluated by motor	797
supraspinal pathways	797
motor	831
potentials and modest recovery of hindlimb movements	844
potentials	844
modest recovery of hindlimb movements	859
modest recovery	859
hindlimb movements	878
addition	901
OEC grafts	911
lumbar reflex hyperexcitability	930
the first month	967
transplantation	989
Histological results	1006
OECs	1041
corticospinal and raphespinal axons regrowth	1058
the injury site	1111
the caudal spinal cord segments	1136
raphespinal but not corticospinal fibers	1184
long distances	1237
the gray matter	1260
the lower lumbar segments -LRB- L5 -RRB- of the spinal cord	1288
the lower lumbar segments -LRB- L5 -RRB-	1288
the lower lumbar segments	1288
L5	1315
the spinal cord	1322
delayed OEC grafts	1348
posttraumatic astrogliosis	1384
conclusion	1415
the beneficial effects found in the present study	1427
the beneficial effects	1427
the present study	1459
the use of OECs	1493
the use	1493
OECs	1504
chronic spinal cord injuries	1522
INTRODUCTION Repairing the injured spinal cord	1553
INTRODUCTION	1553
the injured spinal cord	1576
a clinical challenge	1611
the lack of an effective therapy that promotes long distance axonal regeneration within the human central nervous system	1643
the lack	1643
an effective therapy that promotes long distance axonal regeneration within the human central nervous system	1655
an effective therapy	1655
long distance axonal regeneration	1690
the human central nervous system	1731
the last years	1786
several experimental approaches	1801
evidences	1847
the injured spinal cord	1862
them	1909
olfactory ensheathing cell -LRB- OEC -RRB- transplants	1915
olfactory ensheathing cell	1915
OEC	1943
one of the strategies	1972
one	1972
the strategies	1979
more encouraging results	1999
OEC grafts within the injured spinal cord	2025
OEC grafts	2025
the injured spinal cord	2043
neural protection -LRB- L opez-Vales et al. , 2004a ; Ramer et al. , 2004 ; Verd u et al. , 2001 , 2003 -RRB- , axonal regeneration -LRB- L opez-Vales et al. , 2006 ; Ram on-Cueto et al. , 2000 -RRB- , and remyelination -LRB- Imaizumi et al. , 2000 ; Sasaki et al. , 2006a -RRB-	2097
neural protection -LRB- L opez-Vales et al. , 2004a ; Ramer et al. , 2004 ; Verd u et al. , 2001 , 2003 -RRB- , axonal regeneration -LRB- L opez-Vales et al. , 2006 ; Ram on-Cueto et al. , 2000 -RRB- , and remyelination	2097
neural protection -LRB- L opez-Vales et al. , 2004a ; Ramer et al. , 2004 ; Verd u et al. , 2001 , 2003 -RRB-	2097
neural protection	2097
L opez-Vales et al. , 2004a ; Ramer et al. , 2004 ; Verd u et al.	2116
L opez-Vales	2116
et al. , 2004a ; Ramer et al. , 2004 ; Verd u et al.	2129
et al. , 2004a	2129
et al.	2129
2004a	2137
Ramer et al. , 2004	2144
Ramer	2144
et al. , 2004	2150
et al.	2150
2004	2158
Verd u et al.	2164
Verd u	2164
et al.	2171
2001 , 2003	2179
2001	2179
2003	2185
axonal regeneration -LRB- L opez-Vales et al. , 2006 ; Ram on-Cueto et al. , 2000 -RRB-	2192
axonal regeneration	2192
L opez-Vales	2213
et al. , 2006 ; Ram on-Cueto et al. , 2000	2226
et al.	2226
2006 ; Ram on-Cueto et al.	2234
2006	2234
Ram on-Cueto et al.	2240
Ram on-Cueto	2240
et al.	2253
2000	2261
remyelination	2272
Imaizumi	2287
et al. , 2000 ; Sasaki et al. , 2006a	2296
et al.	2296
2000 ; Sasaki et al.	2304
2000	2304
Sasaki et al.	2310
Sasaki	2310
et al.	2317
2006a	2325
Sasaki et al. -LRB- 2006b -RRB-	2343
Sasaki et al.	2343
Sasaki	2343
et al.	2350
2006b	2358
neuroprotection of corticospinal neurons	2379
neuroprotection	2379
corticospinal neurons	2398
primary motor cortex	2425
OECs	2451
the transected dorsal spinal cord	2479
the	2479
dorsal spinal cord	2494
addition	2517
partial functional recovery of locomotor abilities evaluated by the open-field test -LRB- L opez - Vales et al. , 2004a -RRB- and by the climbing test -LRB- Ramon - Cueto et al. , 2000 -RRB- , improvement of central spinal cord conduction -LRB- Imaizumi et al. , 2000 ; Sasaki et al. , 2006a -RRB- , and reappearance of motor	2527
partial functional recovery	2527
locomotor abilities evaluated by the open-field test -LRB- L opez - Vales et al. , 2004a -RRB- and by the climbing test -LRB- Ramon - Cueto et al. , 2000 -RRB- , improvement of central spinal cord conduction -LRB- Imaizumi et al. , 2000 ; Sasaki et al. , 2006a -RRB- , and reappearance of motor	2558
locomotor abilities	2558
the open-field test -LRB- L opez - Vales et al. , 2004a -RRB-	2591
the open-field test	2591
L opez	2612
Vales et al. , 2004a	2620
Vales	2620
et al.	2626
2004a	2634
the climbing test -LRB- Ramon - Cueto et al. , 2000 -RRB- , improvement of central spinal cord conduction -LRB- Imaizumi et al. , 2000 ; Sasaki et al. , 2006a -RRB- , and reappearance of motor	2648
the climbing test -LRB- Ramon - Cueto et al. , 2000 -RRB-	2648
the climbing test	2648
Ramon	2667
Cueto et al. , 2000	2674
Cueto	2674
et al.	2680
2000	2688
improvement of central spinal cord conduction -LRB- Imaizumi et al. , 2000 ; Sasaki et al. , 2006a -RRB-	2695
improvement	2695
central spinal cord conduction -LRB- Imaizumi et al. , 2000 ; Sasaki et al. , 2006a -RRB-	2710
central spinal cord conduction	2710
Imaizumi	2742
et al. , 2000 ; Sasaki et al. , 2006a	2751
et al.	2751
2000 ; Sasaki et al.	2759
2000	2759
Sasaki et al.	2765
Sasaki	2765
et al.	2772
2006a	2780
reappearance of motor	2792
reappearance	2792
motor	2808
potentials -LRB- MEPs ; L opez-Vales et al. , 2006 -RRB-	2821
potentials	2821
MEPs ; L opez-Vales et al. , 2006	2833
MEPs	2833
L opez-Vales et al. , 2006	2839
L opez-Vales	2839
et al. , 2006	2852
et al.	2852
2006	2860
animals receiving OEC grafts after spinal cord lesions	2888
animals	2888
OEC grafts	2906
spinal cord lesions	2923
these beneficial results	2958
OECs	3011
injury	3047
The possible utilization of OEC transplants in human patients	3055
The possible utilization	3055
OEC transplants in human patients	3083
OEC transplants	3083
human patients	3102
at least three reasons	3146
cells	3177
the olfactory bulb or mucosa of the patient	3209
the olfactory bulb or mucosa	3209
the patient	3241
some days	3274
enough numbers of cells for transplantation	3303
enough numbers	3303
cells for transplantation	3321
cells	3321
transplantation	3331
human transplantation therapy	3356
the first months	3419
injury	3442
spontaneous recovery	3468
intervention	3496
Third , an effective approach for the injured human spinal cord	3510
Third	3510
an effective approach for the injured human spinal cord	3517
an effective approach	3517
the injured human spinal cord	3543
not only the restoration of acute injuries , but also the repair of lesions originated weeks , months or even years before	3581
the restoration of acute injuries	3590
the restoration	3590
acute injuries	3609
the repair of lesions originated weeks , months or even years before	3634
the repair	3634
lesions	3648
weeks , months or even years	3667
weeks	3667
months	3674
even years	3684
few studies	3711
OEC grafts	3733
chronic spinal cord injuries	3747
Deumens et al. , 2006 ; Keyvan-Fouladi et al. , 2003 ; Lu et al. , 2002 ; Plant et al. , 2003 ; Steward et al. , 2006 ; Takami et al. , 2002	3777
Deumens	3777
et al. , 2006 ; Keyvan-Fouladi et al. , 2003 ; Lu et al. , 2002 ; Plant et al. , 2003 ; Steward et al. , 2006 ; Takami et al. , 2002	3785
et al. , 2006	3785
et al.	3785
2006	3793
Keyvan-Fouladi et al. , 2003	3799
Keyvan-Fouladi	3799
et al. , 2003	3814
et al.	3814
2003	3822
Lu et al. , 2002	3828
Lu	3828
et al. , 2002	3831
et al.	3831
2002	3839
Plant et al. , 2003	3845
Plant	3845
et al. , 2003	3851
et al.	3851
2003	3859
Steward et al. , 2006	3865
Steward	3865
et al. , 2006	3873
et al.	3873
2006	3881
Takami et al. , 2002	3887
Takami	3887
et al. , 2002	3894
et al.	3894
2002	3902
their results	3912
spinal cord contusion in the rat	3957
spinal cord contusion	3957
the rat	3982
immediate transplantation of OECs	3990
immediate transplantation	3990
OECs	4019
locomotor behavior -LRB- Plant et al. , 2003 ; Resnick et al. , 2003 -RRB-	4040
locomotor behavior	4040
Plant	4060
et al. , 2003 ; Resnick et al. , 2003	4066
et al.	4066
2003 ; Resnick et al.	4074
2003	4074
Resnick et al.	4080
Resnick	4080
et al.	4088
2003	4096
7 days delayed transplantation produced a slight improvement , despite that tissue preservation	4110
7 days	4110
transplantation	4125
a slight improvement	4150
that tissue preservation	4180
timings	4227
Plant et al. , 2003	4236
Plant	4236
et al.	4242
2003	4250
another study	4260
7 days delayed OEC grafts after spinal cord contusion	4275
7 days	4275
OEC grafts	4290
spinal cord contusion	4307
slight behavioral improvement	4341
Schwann cell grafts -LRB- Takami et al. , 2002 -RRB-	4402
Schwann cell grafts	4402
Takami	4423
et al. , 2002	4430
et al.	4430
2002	4438
we	4455
1 week delayed OECs transplantation after complete transection of the spinal cord	4469
1 week	4469
OECs transplantation	4484
complete transection of the spinal cord	4511
complete transection	4511
the spinal cord	4535
axonal regeneration and functional recovery	4560
regeneration	4567
a lesser degree than acute grafting -LRB- L opez-Vales et al. , 2006 -RRB-	4612
a lesser degree	4612
acute grafting -LRB- L opez-Vales et al. , 2006 -RRB-	4633
acute grafting	4633
L opez-Vales et al. , 2006	4649
L opez-Vales	4649
et al.	4662
2006	4670
The aim of the present study	4677
The aim	4677
the present study	4688
OECs	4733
the	4757
spinal cord of adult rats when they are transplanted 1 month and a half -LRB- 6 weeks -RRB-	4783
spinal cord	4783
adult rats	4798
they	4814
transplanted 1 month and a half -LRB- 6 weeks -RRB-	4823
transplanted 1 month	4823
a half -LRB- 6 weeks -RRB-	4848
a half	4848
6 weeks	4856
injury	4871
MATERIALS AND METHODS The experimental procedures performed	4880
MATERIALS AND METHODS The experimental procedures	4880
MATERIALS	4880
METHODS The experimental procedures	4894
METHODS	4894
The experimental procedures	4902
the recommendations of the European Union and the US Department of Health	4951
the recommendations of the European Union	4951
the recommendations	4951
the European Union	4974
the US Department of Health	4997
the US Department	4997
Health	5018
the care and use of laboratory animals	5029
the care and use	5029
laboratory animals	5049
the Ethics Committee of our institution	5089
the Ethics Committee	5089
our institution	5113
OEC Cultures and Immunopurification Primary olfactory bulb cultures	5130
OEC Cultures	5130
Immunopurification Primary olfactory bulb cultures	5147
Immunopurification	5147
Primary olfactory bulb cultures	5166
30 postnatal -LRB- P22 ` ÄìP23 -RRB- Sprague	5215
P22 ` ÄìP23	5229
P22	5229
` ÄìP23	5232
` ÄìDawley rats using the method described by Gudi ~ no-Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB-	5247
` ÄìDawley rats using the method described by Gudi ~ no-Cabrera and Nieto-Sampedro	5247
ÄìDawley rats	5248
the method described by Gudi	5268
the method	5268
Gudi	5292
no-Cabrera and Nieto-Sampedro	5297
1996	5328
2000	5334
minor modifications -LRB- L opez-Vales et al. , 2004a , b ; Verd u et al. , 2003 -RRB-	5345
minor modifications	5345
L opez-Vales et al. , 2004a , b ; Verd u et al. , 2003	5366
L opez-Vales	5366
et al. , 2004a , b ; Verd u et al. , 2003	5379
et al.	5379
2004a	5387
b ; Verd u et al.	5393
b	5393
Verd u et al.	5396
Verd u	5396
et al.	5403
2003	5411
olfactory bulbs	5427
the meningeal layer	5457
fine forceps	5499
the bulbs	5517
The cell mixture	5582
centrifugation	5616
flasks precoated with poly-L-lysine -LRB- 10 ¬ µg/mL , Sigma , St Louis -RRB-	5645
flasks	5645
poly-L-lysine -LRB- 10 ¬ µg/mL , Sigma , St Louis -RRB-	5667
poly-L-lysine	5667
10 ¬ µg/mL	5682
Sigma	5693
St Louis	5700
A defined medium	5711
the OECs	5751
confluence -LRB- 7 ` Äì9 days in vitro -RRB-	5776
confluence	5776
7 ` Äì9 days in vitro	5788
7 ` Äì9 days	5788
vitro	5802
OECs	5810
means of magnetic Dynabeads	5851
means	5851
magnetic Dynabeads	5860
M-450 -LRB- Dynal , Oslo , Norway -RRB- precoated with goat anti-mouse IgG and attached with mouse monoclonal 192 IgG antibodies -LRB- MAB365 , Chemicon , Temecula , CA -RRB- that recognize the p75-NGF receptor	5879
M-450 -LRB- Dynal , Oslo , Norway -RRB- precoated with goat anti-mouse IgG and attached with mouse monoclonal 192 IgG antibodies	5879
M-450 -LRB- Dynal , Oslo , Norway -RRB-	5879
M-450	5879
Dynal	5886
Oslo	5893
Norway	5899
goat anti-mouse IgG	5922
mouse monoclonal 192 IgG antibodies	5960
192	5977
MAB365	5997
Chemicon	6005
Temecula , CA	6015
the p75-NGF receptor	6044
The p75	6066
positive OECs	6075
freezing medium -LRB- C - 6295 , Sigma -RRB-	6109
freezing medium	6109
C	6126
6295 , Sigma	6129
6295	6129
Sigma	6135
220 C for 10 min	6161
220 C	6161
10 min	6171
a deep freezer at 280 C. For transplantation , frozen cell vials were thawed at 37 C	6187
a deep freezer	6187
280 C. For transplantation , frozen cell vials were thawed at 37 C	6205
280 C.	6205
transplantation	6216
frozen cell vials	6233
37 C	6266
two times	6279
centrifugation	6292
900 rpm , 7 min	6308
900 rpm	6308
7 min	6317
DMEM/F12	6327
the pellet	6341
the same medium	6367
The cells	6384
2 h of thawing	6419
2 h	6419
thawing	6426
It	6435
frozen and thawed OECs	6476
neural protection and axonal regeneration -LRB- Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2004a , b ; Verd u et al. , 2003 -RRB-	6517
neural protection and axonal regeneration	6517
Garc ƒ	6560
± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2004a , b ; Verd u et al. , 2003	6566
± a-Al ƒ ± as et al.	6566
± a-Al ƒ ±	6566
et al.	6577
2004 ; L opez-Vales et al.	6585
2004	6585
L opez-Vales et al.	6591
L opez-Vales	6591
et al.	6604
2004a	6612
b ; Verd u et al. , 2003	6618
b	6618
Verd u et al. , 2003	6621
Verd u	6621
et al. , 2003	6628
et al.	6628
2003	6636
Surgical Procedure	6643
Female adult Sprague ` ÄìDawley rats -LRB- 250-300 g -RRB- were anesthetized with pentobarbital	6662
Female adult Sprague	6662
ÄìDawley rats -LRB- 250-300 g -RRB-	6683
ÄìDawley rats	6683
250-300 g	6698
40 mg/kg , i.p.	6747
40 mg/kg	6747
laminectomy to expose the T8 ` ÄìT9 thoracic spinal cord segments	6770
the T8 ` ÄìT9 thoracic spinal cord segments	6792
the T8	6792
` ÄìT9 thoracic spinal cord segments	6798
the cord	6835
T8	6873
a microscalpel	6882
Possible remaining adhesions	6898
microscissors	6941
the rostral and caudal stumps	6960
the rostral	6960
caudal stumps	6976
complete transection	7025
The wound	7047
planes	7071
the animals	7082
Forty-five days	7119
the injury	7141
the rats	7153
the thoracic spinal cord area	7186
transplantation	7245
a suspension of OECs	7262
a suspension	7262
OECs	7278
a sterile glass needle -LRB- 80 µm i.d. ; 100 µm o.d. -RRB- connected to a Hamilton syringe	7317
a sterile glass needle -LRB- 80 µm i.d. ; 100 µm o.d. -RRB-	7317
a sterile glass needle	7317
80 µm i.d. ; 100 µm o.d.	7341
80 µm i.d.	7341
100 µm o.d.	7353
a Hamilton syringe	7379
Rats	7399
four injections of OECs -LRB- 375,000 cells in 3 µL each -RRB- , two injections 1 mm cranial and two 1 mm caudal to the lesion epicenter , and at each level one injection at each side 0.5 mm lateral to the cord midline	7413
four injections of OECs -LRB- 375,000 cells in 3 µL each -RRB-	7413
four injections	7413
OECs -LRB- 375,000 cells in 3 µL each -RRB-	7432
OECs	7432
375,000 cells in 3 µL each	7438
375,000 cells	7438
3 µL each	7455
3 µL	7455
each	7460
two injections 1 mm cranial	7467
two injections	7467
1 mm cranial	7482
two 1 mm caudal to the lesion epicenter , and at each level one injection at each side 0.5 mm lateral to the cord midline	7499
two 1 mm caudal	7499
the lesion epicenter	7518
each level one injection at each side 0.5 mm lateral to the cord midline	7547
each level one injection	7547
each side 0.5 mm lateral to the cord midline	7575
each side 0.5 mm lateral	7575
the cord midline	7603
0.5 mm depth -LRB- L opez-Vales et al. , 2006 -RRB-	7623
0.5 mm depth	7623
L opez-Vales et al. , 2006	7637
L opez-Vales	7637
et al.	7650
2006	7658
Each OEC	7665
transplanted rat received a total of 1,500,000 cells	7674
transplanted rat	7674
a total of 1,500,000 cells	7700
a total	7700
1,500,000 cells	7711
OEC group ; n ≠ 10	7728
OEC group	7728
n ≠ 10	7739
n	7739
10	7743
Control animals	7748
12 µL of DMEM/F12 distributed at the same	7773
12 µL	7773
DMEM/F12 distributed at the same	7782
DMEM/F12	7782
the same	7806
the same day postinjury -LRB- DM group ; n ≠ 8 -RRB-	7830
the same day postinjury	7830
DM group ; n ≠ 8	7855
DM group	7855
n ≠ 8	7865
n	7865
8	7869
All rats	7873
a 12 h light/dark cycle	7898
water and food ad libitum	7935
Bladders	7962
twice a day	7986
reflex voiding of the bladder	8004
reflex voiding	8004
the bladder	8022
All animals	8051
the first operation	8072
the spinal cord injury	8096
two rats of group DM	8129
two rats	8129
group DM	8141
the second surgery performed for delayed transplantation	8162
the second surgery	8162
delayed transplantation	8195
Behavioral Assessment Locomotor activity	8220
Behavioral Assessment Locomotor	8220
activity	8252
the open-field walking test	8281
the locomotor ability	8320
5 min	8349
One animal at a time	8356
One animal	8356
a time	8370
a circular plastic tray -LRB- 90 cm diameter x 24 cm wall height -RRB-	8411
a circular plastic tray	8411
90 cm diameter x 24 cm wall height	8436
90 cm diameter	8436
24 cm wall height	8453
Two independent examiners	8473
the hindlimb movements of the rat	8508
the hindlimb movements	8508
the rat	8534
the locomotor function	8554
the Basso , Beattie and Bresnahan scale -LRB- BBB scale -RRB- that ranges from 0 -LRB- paralysis -RRB- to 21 points -LRB- normal gait -RRB- -LRB- Basso et al. , 1995 -RRB-	8590
the Basso , Beattie and Bresnahan scale	8590
BBB scale	8630
0 -LRB- paralysis -RRB- to 21 points -LRB- normal gait -RRB- -LRB- Basso et al. , 1995 -RRB-	8658
0 -LRB- paralysis -RRB-	8658
21 points -LRB- normal gait -RRB- -LRB- Basso et al. , 1995 -RRB-	8675
21 points -LRB- normal gait -RRB-	8675
21 points	8675
normal gait	8686
Basso	8700
et al. , 1995	8706
et al.	8706
1995	8714
The score of each animal	8721
The score	8721
each animal	8734
the mean value of both examiners	8750
the mean value	8750
both examiners	8768
Electrophysiological Evaluation Electrophysiological tests	8784
all rats	8861
surgery	8877
transplantation	8895
animals	8926
evidence	8944
complete transection of the cord	8956
complete transection	8956
the cord	8980
monthly intervals	9002
5 months after transplantation	9026
5 months	9026
transplantation	9041
MEPs	9058
the function of spinal cord descending tracts -LRB- Garc ƒ ± a-Al ƒ ± as et al. , 2003 -RRB-	9085
the function	9085
spinal cord descending tracts	9101
Garc ƒ ± a-Al ƒ ± as et al. , 2003	9132
Garc ƒ	9132
± a-Al ƒ ± as et al. , 2003	9138
± a-Al ƒ ±	9138
et al. , 2003	9149
et al.	9149
2003	9157
MEPs	9164
supramaximal electrical stimulation -LRB- single pulses of 0.1 ms duration and 25 mA intensity -RRB- of the motor cortex	9184
supramaximal electrical stimulation -LRB- single pulses of 0.1 ms duration and 25 mA intensity -RRB-	9184
supramaximal electrical stimulation	9184
single pulses of 0.1 ms	9221
single pulses	9221
0.1 ms	9238
duration and 25 mA intensity	9245
the motor cortex	9278
needle electrodes inserted subcutaneously , the cathode over the skull overlying the motor area and the anode at the nose , and recorded from the contralateral gastrocnemius muscle	9303
needle electrodes	9303
the cathode over the skull	9346
the cathode	9346
the skull	9363
the motor area and the anode	9383
the motor area	9383
the anode	9402
the nose	9415
the contralateral gastrocnemius muscle	9443
The signals	9483
the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude and the latency of the evoked potentials	9538
the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude	9538
Sapphire 4ME	9556
Vickers	9570
the amplitude	9590
the latency of the evoked potentials	9608
the latency	9608
the evoked potentials	9623
the	9623
potentials	9634
The noninvasive method applied	9646
The noninvasive method	9646
consistent evaluation of MEPs in the same animal	9684
consistent evaluation	9684
MEPs in the same animal	9709
MEPs	9709
the same animal	9717
time -LRB- L opez - Vales et al. , 2006 ; Valero-Cabr e et al. , 2004 -RRB-	9749
time	9749
L opez	9755
Vales et al. , 2006 ; Valero-Cabr e et al. , 2004	9763
Vales	9763
et al. , 2006 ; Valero-Cabr e et al. , 2004	9769
et al. , 2006	9769
et al.	9769
2006	9777
Valero-Cabr e et al. , 2004	9783
Valero-Cabr e et al.	9783
Valero-Cabr	9783
et al.	9797
2004	9805
lumbar spinal reflexes	9822
the sciatic nerve	9846
single electrical pulses of 0.1 ms duration up to supramaximal intensity delivered by monopolar needles inserted percutaneously at the sciatic notch	9884
single electrical pulses	9884
0.1 ms duration	9912
supramaximal intensity delivered by monopolar needles inserted percutaneously at the sciatic notch	9934
supramaximal intensity	9934
monopolar needles inserted percutaneously at the sciatic notch	9970
monopolar needles	9970
the sciatic notch	10015
Compound muscle action potentials , including the direct muscle response -LRB- M-wave -RRB- and the monosynaptic reflex response -LRB- H-wave -RRB- , of the plantar muscles	10034
Compound muscle action potentials , including the direct muscle response -LRB- M-wave -RRB- and the monosynaptic reflex response -LRB- H-wave -RRB- ,	10034
Compound muscle action potentials	10034
the direct muscle response -LRB- M-wave -RRB- and the monosynaptic reflex response -LRB- H-wave -RRB-	10079
the direct muscle response	10079
M-wave	10107
the monosynaptic reflex response	10119
H-wave	10153
the plantar muscles	10165
means of needle electrodes	10202
means	10202
needle electrodes	10211
the oscilloscope	10258
the amplitude and the latency of M - and H-waves	10286
the amplitude	10286
the latency of M	10304
the latency	10304
M	10319
H-waves	10326
The H/M amplitude ratio	10335
percentage of the preoperative values	10391
percentage	10391
the preoperative values	10405
The H/M ratio	10430
either partial or complete spinal cord injuries -LRB- L opez-Vales et al. , 2006 ; Valero-Cabr e et al. , 2004 -RRB-	10460
either partial or complete spinal cord injuries	10460
L opez-Vales	10509
et al. , 2006 ; Valero-Cabr e et al. , 2004	10522
et al.	10522
2006 ; Valero-Cabr e et al.	10530
2006	10530
Valero-Cabr e et al.	10536
Valero-Cabr	10536
et al.	10550
2004	10558
H-reflex facilitation	10576
interruption of supraspinal motor control	10605
interruption	10605
supraspinal motor control	10621
the Corticospinal Tract	10659
corticospinal axons	10701
the lesion site	10752
the corticospinal tract	10769
biotin dextran amine -LRB- BDA ; 10,000 MW ; Molecular Probes , Eugene , OR -RRB-	10824
biotin dextran amine	10824
BDA ; 10,000 MW ; Molecular Probes	10846
BDA	10846
10,000 MW ; Molecular Probes	10851
10,000 MW	10851
Molecular Probes	10862
Eugene , OR	10880
Eugene	10880
OR	10888
5 months after transplantation -LRB- i.e. , 6.5 months after injury -RRB-	10896
5 months	10896
transplantation	10911
i.e. , 6.5 months	10928
i.e.	10928
6.5 months	10934
injury	10951
rats	10959
anesthetized , placed in a stereotaxic frame	10969
anesthetized	10969
a stereotaxic frame	10993
two holes	11018
the cranium	11046
both sensorimotor cortices	11068
a single injection per hemisphere of 1 µL of a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11102
a single injection	11102
hemisphere of 1 µL of a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11125
hemisphere	11125
1 µL of a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11139
1 µL	11139
a 10 % BDA solution in 0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11147
a 10 % BDA solution	11147
0.01 M phosphate buffer -LRB- pH 7.2 -RRB-	11169
0.01 M phosphate buffer	11169
pH 7.2	11193
0.5 mm caudal and 2.5 mm lateral	11213
0.5 mm caudal	11213
2.5 mm lateral	11231
bregma	11251
a depth of 1.5 mm from the skull surface , using a 10-µL Hamilton syringe that remained in place for 2 min after injection -LRB- Schucht et al. , 2002 -RRB-	11262
a depth	11262
1.5 mm	11273
the skull surface	11285
a 10-µL Hamilton syringe	11310
place for 2 min	11352
place	11352
2 min	11362
injection -LRB- Schucht et al. , 2002 -RRB-	11374
injection	11374
Schucht	11385
et al. , 2002	11393
et al.	11393
2002	11401
BDA-labeled corticospinal axons	11408
Cy2 or Cy3	11465
avidin	11487
Äì biotin complex -LRB- 1:200 , Jackson Immunoresearch , West Grove , PA -RRB-	11494
Äì biotin complex	11494
1:200 , Jackson Immunoresearch , West Grove , PA	11513
1:200	11513
Jackson Immunoresearch	11520
West Grove	11544
PA	11556
Histological Evaluation Two weeks following BDA injection , rats	11561
Histological Evaluation Two weeks	11561
BDA injection , rats	11605
BDA injection	11605
rats	11620
4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	11659
4 % paraformaldehyde	11659
0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	11682
0.1 M phosphate buffer	11682
pH 7.4	11705
Spinal cord segments from T6-T10 and L5	11714
Spinal cord segments	11714
T6-T10 and L5	11740
postfixed overnight in the same fixative , and cryoprotected in 30 % sucrose at 4 °C	11770
postfixed overnight in the same fixative , and cryoprotected in 30 % sucrose	11770
the same fixative	11793
30 %	11833
4 °C	11848
Spinal cord segments	11853
TissueTek -LRB- Sakumura , Netherlands -RRB-	11891
TissueTek	11891
Sakumura	11902
Netherlands	11912
serially in the sagital -LRB- T6 ` ÄìT10 block -RRB- or transversal -LRB- L5 block -RRB- plane	11933
the sagital -LRB- T6 ` ÄìT10 block -RRB- or transversal -LRB- L5 block -RRB-	11945
the sagital -LRB- T6 ` ÄìT10 block -RRB-	11945
the sagital	11945
T6 ` ÄìT10 block	11958
T6	11958
ÄìT10 block	11961
transversal -LRB- L5 block -RRB-	11977
transversal	11977
L5 block	11990
a cryostat	12009
15 µm thickness	12023
Sections	12040
gelatin-coated glass slides washed with phosphate-buffer saline -LRB- PBS , 0.1 M , pH 7.4 -RRB- , incubated in PBS with 0.5 % Triton-X-100 -LRB- Fluka , Madrid , Spain -RRB- and 5 % FCS -LRB- Biological Industries , Israel -RRB- for 1 h , and then overnight at 4 °C with primary antibodies	12069
gelatin-coated glass slides	12069
phosphate-buffer saline -LRB- PBS , 0.1 M , pH 7.4 -RRB- , incubated in PBS with 0.5 % Triton-X-100 -LRB- Fluka , Madrid , Spain -RRB- and 5 % FCS -LRB- Biological Industries , Israel -RRB- for 1 h , and then overnight at 4 °C with primary antibodies	12109
phosphate-buffer saline -LRB- PBS , 0.1 M , pH 7.4 -RRB-	12109
phosphate-buffer saline	12109
PBS	12134
0.1 M	12139
pH 7.4	12145
PBS with 0.5 % Triton-X-100 -LRB- Fluka , Madrid , Spain -RRB- and 5 % FCS -LRB- Biological Industries , Israel -RRB- for 1 h , and then overnight at 4 °C	12167
PBS with 0.5 % Triton-X-100 -LRB- Fluka , Madrid , Spain -RRB-	12167
PBS	12167
0.5 % Triton-X-100 -LRB- Fluka , Madrid , Spain -RRB-	12176
0.5 % Triton-X-100	12176
Fluka	12195
Madrid	12202
Spain	12210
5 % FCS -LRB- Biological Industries , Israel -RRB- for 1 h , and then overnight at 4 °C	12221
5 % FCS	12221
Biological Industries , Israel	12229
Biological Industries	12229
Israel	12252
1 h	12264
then overnight at 4 °C	12273
then overnight	12273
4 °C	12291
primary antibodies	12300
The following antibodies	12320
: rabbit polyclonal antibody against serotonin -LRB- 5HT ; 1:100 , Diasorin -RRB- , mouse monoclonal antibodies against glial fibrillary acidic protein -LRB- GFAP ; G-3893 , 1:2000 ; Sigma -RRB- and against p75 neurotrophin receptor -LRB- p75NTR ; MAB365 , 1:200 , Chemicon -RRB- , and goat polyclonal antibody against choline acetyltransferase -LRB- ChAT ; AB 144P , 1:50 , Chemicon -RRB-	12354
: rabbit polyclonal antibody against serotonin -LRB- 5HT ; 1:100 , Diasorin -RRB- , mouse monoclonal antibodies against glial fibrillary acidic protein -LRB- GFAP ; G-3893 , 1:2000 ; Sigma -RRB- and against p75 neurotrophin receptor -LRB- p75NTR ; MAB365 , 1:200 , Chemicon -RRB-	12354
rabbit polyclonal antibody against serotonin -LRB- 5HT ; 1:100 , Diasorin -RRB-	12356
rabbit polyclonal antibody	12356
serotonin -LRB- 5HT ; 1:100 , Diasorin -RRB-	12391
serotonin	12391
5HT ; 1:100 , Diasorin	12402
5HT	12402
1:100 , Diasorin	12407
1:100	12407
Diasorin	12414
mouse monoclonal antibodies against glial fibrillary acidic protein -LRB- GFAP ; G-3893 , 1:2000 ; Sigma -RRB- and against p75 neurotrophin receptor -LRB- p75NTR ; MAB365 , 1:200 , Chemicon -RRB-	12425
mouse monoclonal antibodies	12425
glial fibrillary acidic protein -LRB- GFAP ; G-3893 , 1:2000 ; Sigma -RRB-	12461
glial fibrillary acidic protein	12461
GFAP ; G-3893	12494
GFAP	12494
G-3893	12500
1:2000 ; Sigma	12508
1:2000	12508
Sigma	12516
p75 neurotrophin receptor -LRB- p75NTR ; MAB365 , 1:200 , Chemicon -RRB-	12535
p75 neurotrophin receptor	12535
p75NTR ; MAB365	12562
p75NTR	12562
MAB365	12570
1:200 , Chemicon	12578
1:200	12578
Chemicon	12585
goat polyclonal antibody against choline acetyltransferase -LRB- ChAT ; AB 144P , 1:50 , Chemicon -RRB-	12600
goat polyclonal antibody	12600
choline acetyltransferase -LRB- ChAT ; AB 144P , 1:50 , Chemicon -RRB-	12633
choline acetyltransferase	12633
ChAT ; AB 144P	12660
ChAT	12660
AB 144P	12666
1:50 , Chemicon	12675
1:50	12675
Chemicon	12681
washes	12698
sections	12706
Cy2 or Cy3	12735
immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB-	12757
immunoglobulin G	12757
1:200	12775
Jackson Immunoresearch	12782
3 h	12810
room temperature	12817
additional washes with PBS	12845
additional washes	12845
PBS	12868
sections	12873
ethanol	12901
DPX -LRB- Fluka -RRB-	12931
DPX	12931
Fluka	12936
negative controls	12948
some sections	12967
the omission of primary antibodies	13014
the omission	13014
primary antibodies	13030
Sagital spinal cord sections from the T6 ` ÄìT10 block	13050
Sagital spinal cord sections	13050
the T6 ` ÄìT10 block	13084
the density of corticospinal and serotonergic axons	13129
the density	13129
corticospinal and serotonergic axons	13144
Images from serotonin and BDA	13182
Images	13182
serotonin and BDA	13194
spinal cord sections -LRB- 3200 -RRB-	13220
spinal cord sections	13220
3200	13242
the lesion epicenter as well as 1 mm cranial and 1 mm caudal	13264
the lesion epicenter	13264
1 mm cranial and 1 mm caudal	13296
1 mm cranial	13296
1 mm caudal	13313
the lesion edge	13328
Fiber quantification	13345
the number of pixels occupied by stained fibers per area -LRB- µm2 -RRB- after defining a threshold for background correction -LRB- Bradburry et al. , 1999 ; L opez-Vales et al. , 2006 -RRB-	13390
the number	13390
pixels occupied by stained fibers per area -LRB- µm2 -RRB- after defining a threshold for background correction -LRB- Bradburry et al. , 1999 ; L opez-Vales et al. , 2006 -RRB-	13404
pixels	13404
fibers per area -LRB- µm2 -RRB-	13431
fibers	13431
area -LRB- µm2 -RRB-	13442
area	13442
µm2	13448
a threshold for background correction -LRB- Bradburry et al. , 1999 ; L opez-Vales et al. , 2006 -RRB-	13468
a threshold	13468
background correction -LRB- Bradburry et al. , 1999 ; L opez-Vales et al. , 2006 -RRB-	13484
background correction	13484
Bradburry	13507
et al. , 1999 ; L opez-Vales et al. , 2006	13517
et al.	13517
1999 ; L opez-Vales et al.	13525
1999	13525
L opez-Vales et al.	13531
L opez-Vales	13531
et al.	13544
2006	13552
assessment of astrocyte reactivity	13563
assessment	13563
astrocyte reactivity	13577
images of the spinal cord stained for GFAP	13599
images	13599
the spinal cord stained for GFAP	13609
the spinal cord	13609
GFAP	13637
5003 magnification at 1 mm cranial and 1 mm caudal	13656
5003 magnification	13656
1 mm cranial and 1 mm caudal	13678
1 mm cranial	13678
1 mm caudal	13695
the lesion edge	13710
quantitative analysis series of eight spinal cord sections -LRB- 15 µm thick -RRB- separated by 135	13731
quantitative analysis series	13731
eight spinal cord sections -LRB- 15 µm thick -RRB- separated by 135	13763
eight spinal cord sections	13763
15 µm	13791
135	13817
µm intervals	13821
GFAP in each rat	13853
GFAP	13853
each rat	13861
Images	13871
the aid of a digital camera -LRB- Olympus DP50 -RRB- attached to the microscope and then analyzed using NIH Image software	13894
the aid	13894
a digital camera -LRB- Olympus DP50 -RRB- attached to the microscope and then analyzed using NIH Image software	13905
a digital camera	13905
Olympus DP50	13923
the microscope	13949
NIH Image software	13988
The intensity of GFAP labeling ranging on a scale between 0 -LRB- no fluorescence -RRB- and 255 -LRB- maximal fluorescence -RRB-	14008
The intensity	14008
GFAP labeling ranging on a scale between 0 -LRB- no fluorescence -RRB- and 255 -LRB- maximal fluorescence -RRB-	14025
GFAP labeling	14025
a scale between 0 -LRB- no fluorescence -RRB- and 255 -LRB- maximal fluorescence -RRB-	14050
a scale	14050
0 -LRB- no fluorescence -RRB- and 255 -LRB- maximal fluorescence -RRB-	14066
0	14066
no fluorescence	14069
255	14090
maximal fluorescence	14095
each animal	14135
the immunoreactivity degree of GFAP	14147
the immunoreactivity degree	14147
GFAP	14178
the mean of values obtained in 12 serial sections -LRB- Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2006 -RRB-	14187
the mean	14187
values obtained in 12 serial sections -LRB- Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2006 -RRB-	14199
values	14199
12 serial sections -LRB- Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2006 -RRB-	14218
12 serial sections	14218
Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2006	14238
Garc ƒ	14238
± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2006	14244
± a-Al ƒ ± as et al. , 2004	14244
± a-Al ƒ ±	14244
et al. , 2004	14255
et al.	14255
2004	14263
L opez-Vales et al. , 2006	14269
L opez-Vales	14269
et al. , 2006	14282
et al.	14282
2006	14290
each group	14306
a mean value	14317
each animal value	14351
variability	14380
sections from the different groups	14393
sections	14393
the different groups	14407
the setting for image acquisition	14462
the setting	14462
image acquisition	14478
the same for all the images stained against the same marker	14500
the same	14500
all the images stained against the same marker	14513
all the images	14513
the same marker	14544
Statistical Analysis Functional , electrophysiological , and histological measurements	14561
Statistical Analysis Functional	14561
electrophysiological , and histological measurements	14594
a blinded manner	14664
a code of rats and histological slides	14690
a code	14690
rats and histological slides	14700
rats	14700
histological slides	14709
Data	14730
the mean = SEM	14752
Statistical comparisons between results of the two groups	14768
Statistical comparisons	14768
results of the two groups	14800
results	14800
the two groups	14811
t-test	14839
Differences	14847
P	14890
Regression analysis	14900
the relationship between the amplitude of MEPs and the BBB score	14939
the relationship	14939
the amplitude of MEPs and the BBB score	14964
the amplitude	14964
MEPs and the BBB score	14981
MEPs	14981
the BBB score	14990
RESULTS	15006
1	15019
Plots showing the time course of functional recovery assessed using the BBB score -LRB- A -RRB- and of the amplitude of MEPs recorded in the gastrocnemius muscle -LRB- B -RRB- .	15022
Plots	15022
the time course	15036
functional recovery assessed using the BBB score -LRB- A -RRB-	15055
functional recovery	15055
the BBB score -LRB- A -RRB-	15090
the BBB score	15090
A	15105
the amplitude of MEPs recorded in the gastrocnemius muscle -LRB- B -RRB-	15115
the amplitude	15115
MEPs recorded in the gastrocnemius muscle -LRB- B -RRB-	15132
MEPs	15132
the gastrocnemius muscle -LRB- B -RRB-	15149
the gastrocnemius muscle	15149
B	15175
Scatter plot showing the final BBB values of DM-injected animals and OEC-transplanted animals that recovered MEPs -LRB- MR -RRB- or did not recover MEPs -LRB- no MR -RRB- -LRB- C -RRB- .	15179
Scatter plot	15179
the final BBB values of DM-injected animals and OEC-transplanted animals that recovered MEPs -LRB- MR -RRB- or did not recover MEPs -LRB- no MR -RRB- -LRB- C -RRB-	15200
the final BBB values of DM-injected animals	15200
the final BBB values	15200
DM-injected animals	15224
OEC-transplanted animals that recovered MEPs -LRB- MR -RRB- or did not recover MEPs -LRB- no MR -RRB- -LRB- C -RRB-	15248
OEC-transplanted animals	15248
MEPs -LRB- MR -RRB-	15288
MEPs	15288
MR	15294
MEPs -LRB- no MR -RRB- -LRB- C -RRB-	15317
MEPs -LRB- no MR -RRB-	15317
MEPs	15317
no MR	15323
C	15331
only OEC-grafted animals with MEP responses	15345
only OEC-grafted animals	15345
MEP responses	15375
improvement	15396
the BBB score	15411
Plot showing the H/M amplitude ratio along time -LRB- D -RRB- .	15426
Plot	15426
the H/M amplitude ratio along time -LRB- D -RRB-	15439
the H/M amplitude ratio	15439
time -LRB- D -RRB-	15469
time	15469
D	15475
H/M ratio	15479
percentage of the preoperative values	15505
percentage	15505
the preoperative values	15519
the H	15554
M ratio	15561
OEC-grafted rats	15589
the transplant in contrast	15612
the transplant	15612
contrast	15630
the progressive increase shown by DMrats	15644
the progressive increase	15644
DMrats	15678
Arrows	15686
the time of delayed transplantation	15702
the time	15702
delayed transplantation	15714
P <	15740
P	15740
<	15742
0.05	15744
P	15752
< 0.01 , *** P <	15754
<	15754
0.01 , *** P <	15756
0.01	15756
*** P <	15762
*** P	15762
<	15767
0.001 compared with group DM ; ## P < 0.01 compared with subgroup OEC that did not recover MEPs	15769
0.001	15769
group DM ; ## P < 0.01	15789
group DM ; ## P <	15789
group DM	15789
group	15789
DM	15795
P <	15801
0.01	15805
subgroup OEC that did not recover MEPs	15824
subgroup OEC	15824
MEPs	15858
Fig. 2 .	15865
Fig.	15865
2	15870
Representative electrophysiological recordings of MEPs in rats of groups OEC and DM .	15873
Representative electrophysiological recordings	15873
MEPs	15923
rats of groups OEC and DM	15931
rats	15931
groups OEC and DM	15939
groups OEC	15939
DM	15954
MEPs	15958
OEC rats	15977
2 months	15989
105 dpo	16014
MEPs in OEC-grafted animals	16024
MEPs	16024
OEC-grafted animals	16032
amplitude	16065
latency along time	16093
latency	16093
time	16107
contrast	16116
MEPs	16126
all the animals of group DM	16153
all the animals	16153
group DM	16172
the 7 months postinjury	16188
Fig. 3 .	16214
Fig.	16214
3	16219
Representative electrophysiological recordings of M and H waves	16222
Representative electrophysiological recordings	16222
M and H waves	16272
stimulation of the sciatic nerve	16296
stimulation	16296
the sciatic nerve	16311
rats of groups DM and OEC , obtained from 2 to 5 months after delayed transplantation	16332
rats	16332
groups DM and OEC , obtained from 2 to 5 months after delayed transplantation	16340
groups DM and OEC	16340
2 to 5 months	16373
delayed transplantation	16393
the larger H wave amplitude	16423
DM rats in comparison	16454
DM rats	16454
comparison	16465
OEC-transplanted rats	16481
Fig. 4 .	16505
Fig.	16505
4	16510
Sagital sections of the thoracic spinal cord	16513
Sagital sections	16513
the thoracic spinal cord	16533
BDA	16570
representative rats of group DM -LRB- A -RRB- and group OEC -LRB- B -RRB-	16577
representative rats	16577
group DM -LRB- A -RRB- and group OEC -LRB- B -RRB-	16600
group DM	16600
A	16610
group OEC	16617
B	16628
High magnification images	16632
a rat of group OEC	16672
a rat	16672
group OEC	16681
the presence of BDA-labeled corticospinal -LRB- C -RRB-	16699
the presence	16699
BDA-labeled corticospinal -LRB- C -RRB-	16715
BDA-labeled corticospinal	16715
C	16742
serotonergic -LRB- D -RRB- fibers	16749
D	16763
the caudal spinal cord stump	16776
Histogram graph of the degree of reactivity of BDA -LRB- E -RRB- and serotonin -LRB- F -RRB- positive axons at rostral , epicenter , and caudal regions of the transected spinal cord .	16806
Histogram	16806
graph of the degree of reactivity of BDA -LRB- E -RRB- and serotonin -LRB- F -RRB-	16816
graph	16816
the degree of reactivity of BDA -LRB- E -RRB- and serotonin -LRB- F -RRB-	16825
the degree	16825
reactivity of BDA -LRB- E -RRB- and serotonin -LRB- F -RRB-	16839
reactivity	16839
BDA -LRB- E -RRB- and serotonin -LRB- F -RRB-	16853
BDA	16853
E	16858
serotonin	16865
F	16876
positive axons at rostral	16879
positive axons	16879
rostral	16897
epicenter	16906
caudal regions of the transected spinal cord	16921
caudal regions	16921
the transected spinal cord	16939
P <	16968
P	16968
<	16970
0.05	16972
P < 0.01 , and *** P <	16980
P	16980
< 0.01 , and *** P <	16982
< 0.01	16982
<	16982
0.01	16984
*** P <	16994
*** P	16994
<	16999
0.001 compared with group DM	17001
0.001	17001
group DM	17021
Bar	17031
2 ¬ µm in A and B , and 50 ¬ µm	17037
2 ¬ µm in A and B	17037
2 ¬ µm	17037
A and B	17046
50 ¬ µm	17059
C and D. Fig. 5	17069
C	17069
D. Fig. 5	17075
Transverse section of the L5 spinal cord	17087
Transverse section	17087
the L5 spinal cord	17109
serotonin	17146
an animal transplanted with OECs -LRB- A -RRB-	17159
an animal transplanted	17159
OECs -LRB- A -RRB-	17187
OECs	17187
A	17193
High magnification images showing serotonergic fibers -LRB- arrows -RRB- at ventral -LRB- B -RRB- and central -LRB- C -RRB- gray matter areas taken from the boxes	17197
High magnification images	17197
serotonergic fibers -LRB- arrows -RRB-	17231
serotonergic fibers	17231
arrows	17252
ventral -LRB- B -RRB- and central -LRB- C -RRB- gray matter areas taken from the boxes	17263
ventral -LRB- B -RRB- and central -LRB- C -RRB- gray matter areas	17263
B	17272
C	17288
the boxes	17320
A	17344
Bar	17348
500 ¬ µm in A , and 50 ¬ µm	17354
500 ¬ µm in A	17354
500 ¬ µm	17354
A	17365
50 ¬ µm	17372
B and C. Fig. 6	17382
B	17382
C. Fig. 6	17388
Representative images of astrogliosis from groups DM -LRB- A -RRB- and OEC -LRB- B -RRB-	17400
Representative images	17400
astrogliosis from groups DM -LRB- A -RRB- and OEC -LRB- B -RRB-	17425
astrogliosis	17425
groups DM -LRB- A -RRB- and OEC -LRB- B -RRB-	17443
groups DM	17443
A	17454
OEC	17461
B	17466
regions	17480
the lesion edge	17496
Histogram representation of the GFAP immunoreactivity rostral and caudal to the lesion -LRB- C -RRB- .	17513
Histogram representation	17513
the GFAP immunoreactivity rostral and caudal	17541
the GFAP immunoreactivity rostral	17541
caudal	17579
the lesion -LRB- C -RRB-	17589
the lesion	17589
C	17601
Bar	17605
50 ¬	17611
µm	17615
Functional Outcome Spinal cord transection	17620
Functional Outcome	17620
Spinal cord transection	17639
complete paralysis of both hindlimbs	17670
complete paralysis	17670
both hindlimbs	17692
the first week	17714
injury	17735
a score of 0	17756
a score	17756
0	17767
the BBB scale	17772
the first 45 days	17794
all animals	17829
complete absence of hindlimb movements , slight movements of one or two joints , or rarely extensive movements of one hindlimb joint -LRB- scores 0-2 -RRB-	17848
complete absence of hindlimb movements	17848
complete absence	17848
hindlimb movements	17868
slight movements of one or two joints	17888
slight movements	17888
one or two joints	17908
rarely extensive movements of one hindlimb joint -LRB- scores 0-2 -RRB-	17930
rarely extensive movements	17930
one hindlimb joint -LRB- scores 0-2 -RRB-	17960
one hindlimb joint	17960
scores 0-2	17980
scores	17980
0-2	17987
None of the rats	17993
None	17993
the rats	18001
a BBB score	18020
2	18044
This pattern	18047
DM-injected animals	18076
all the follow-up	18103
a mean BBB score of 0.92 ± 0.15 at the end of the study -LRB- Fig. 1A -RRB-	18127
a mean BBB score	18127
0.92 ± 0.15	18147
the end of the study -LRB- Fig. 1A -RRB-	18162
the end	18162
the study -LRB- Fig. 1A -RRB-	18173
the study	18173
Fig. 1A	18184
Animals receiving an OEC transplant	18194
Animals	18194
an OEC transplant	18212
a similar pattern for locomotion testing during the first 2 months	18240
a similar pattern	18240
locomotion testing during the first 2 months	18262
locomotion testing	18262
the first 2 months	18288
the third month	18343
the end of the follow-up	18362
the end	18362
the follow-up	18373
6 of the 10 transplanted rats slightly	18388
6	18388
the 10 transplanted rats slightly	18393
the 10 transplanted rats	18393
their walking capability	18436
slight or extensive movement of two or three hindlimb joints	18470
slight or extensive movement	18470
two or three hindlimb joints	18502
two	18502
three hindlimb joints	18509
contrast	18535
four of the transplanted animals	18545
four	18545
the transplanted animals	18553
low BBB scores	18585
DMinjected rats	18611
the end of the study	18631
the end	18631
the study	18642
OEC-transplanted animals	18653
a mean BBB score of 2.50 ± 0.50 -LRB- P < 0.05 -RRB- -LRB- Fig. 1A -RRB-	18687
a mean BBB score	18687
2.50 ± 0.50 -LRB- P < 0.05 -RRB- -LRB- Fig. 1A -RRB-	18707
2.50 ± 0.50 -LRB- P < 0.05 -RRB-	18707
2.50 ± 0.50	18707
P < 0.05	18720
P	18720
< 0.05	18722
<	18722
0.05	18724
Fig. 1A	18731
Partial recovery of locomotion after spinal cord transection	18741
Partial recovery	18741
locomotion after spinal cord transection	18761
locomotion	18761
spinal cord transection	18778
the reestablishment of supraspinal connections	18832
the reestablishment	18832
supraspinal connections	18855
changes in lumbar reflex circuits	18885
changes	18885
lumbar reflex circuits	18896
The electrophysiological tests performed	18920
The electrophysiological tests	18920
complete interruption of spinal motor pathways	18974
complete interruption	18974
spinal motor pathways	18999
the injury	19027
DM-injected animals	19042
MEPs	19063
time	19089
interruption of supraspinal axons	19111
interruption	19111
supraspinal axons	19127
the end of the follow-up -LRB- Figs. 1B and 2 -RRB-	19166
the end	19166
the follow-up -LRB- Figs. 1B and 2 -RRB-	19177
the follow-up	19177
Figs. 1B and 2	19192
Figs. 1B	19192
2	19205
contrast , in 6 of the 10 OEC	19212
contrast	19212
6 of the 10 OEC	19225
6	19225
the 10 OEC	19230
transplanted rats MEPs	19241
between 2 and 3 months	19275
partial restitution of motor pathways -LRB- P < 0.0001 -RRB-	19325
partial restitution	19325
motor pathways -LRB- P < 0.0001 -RRB-	19348
motor pathways	19348
P < 0.0001	19364
P	19364
< 0.0001	19366
<	19366
0.0001	19368
The recorded MEPs	19377
amplitude	19408
latency	19435
follow-up -LRB- see Fig. 2 -RRB-	19450
follow-up	19450
Fig. 2	19465
progressive regeneration and myelination of motor descending axons	19494
progressive regeneration and myelination	19494
motor descending axons	19538
at 5 months after transplantation the amplitude of MEPs	19576
at 5 months after transplantation the amplitude	19576
5 months	19579
transplantation	19594
MEPs	19627
249	19641
80 µV	19647
25 times lower than in intact control rats	19669
25 times	19669
their latency	19717
20.7 ± 0.9 ms , fourfold higher than controls -LRB- Fig. 1B -RRB- , indicating a limited degree of recovery	19735
20.7 ± 0.9 ms	19735
controls	19771
Fig. 1B	19781
a limited degree of recovery	19802
a limited degree	19802
recovery	19822
a positive correlation	19847
the amplitude of MEPs and the BBB score -LRB- r = 0.84 ; P < 0.01 -RRB-	19888
the amplitude	19888
MEPs and the BBB score -LRB- r = 0.84 ; P < 0.01 -RRB-	19905
MEPs	19905
the BBB score -LRB- r = 0.84 ; P < 0.01 -RRB-	19914
the BBB score	19914
r = 0.84 ; P < 0.01	19929
r = 0.84 ; P <	19929
r = 0.84	19929
r	19929
0.84	19933
P <	19939
P	19939
<	19941
0.01	19943
fact	19953
only the 6 rats of group OEC that recovered MEPs	19959
only the 6 rats	19959
group OEC that recovered MEPs	19978
group OEC	19978
MEPs	20003
improvement of hindlimb movements	20015
improvement	20015
hindlimb movements	20030
the end of the follow-up	20053
the end	20053
the follow-up	20064
the mean BBB score of OEC-grafted animals that recovered MEPs -LRB- OEC-MR -RRB-	20079
the mean BBB score	20079
OEC-grafted animals that recovered MEPs -LRB- OEC-MR -RRB-	20101
OEC-grafted animals	20101
MEPs	20136
OEC-MR	20142
that observed in group DM and in the OEC-transplanted animals without MEPs recovery -LRB- OEC-no MR -RRB- -LRB- P < 0.01 -RRB- -LRB- Fig. 1C -RRB-	20180
that	20180
group DM	20197
the OEC-transplanted animals	20213
MEPs recovery -LRB- OEC-no MR -RRB- -LRB- P < 0.01 -RRB- -LRB- Fig. 1C -RRB-	20250
MEPs recovery -LRB- OEC-no MR -RRB- -LRB- P < 0.01 -RRB-	20250
MEPs recovery -LRB- OEC-no MR -RRB-	20250
MEPs recovery	20250
OEC-no MR	20265
P < 0.01	20277
P	20277
< 0.01	20279
<	20279
0.01	20281
Fig. 1C	20288
It	20298
OEC-transplanted animals that recovered MEPs	20326
OEC-transplanted animals	20326
MEPs	20366
recovery of motor function	20372
recovery	20372
motor function	20384
a plateau	20413
5 months	20426
transplantation , when the study was terminated	20441
transplantation	20441
the study	20463
better motor skills	20505
a longer follow-up	20548
functional recovery	20586
reestablishment of supraspinal pathways instead of increased reflex responses	20617
reestablishment of supraspinal pathways	20617
reestablishment	20617
supraspinal pathways	20636
increased reflex responses	20668
we	20696
lumbar spinal reflex function	20709
means of the H/M ratio	20742
means	20742
the H/M ratio	20751
spinal cord transection	20772
the M wave amplitude	20796
all animals	20838
the follow-up	20856
the H wave amplitude hugely	20879
the H wave	20879
the first months	20924
transection	20947
an increase of the H/M ratio -LRB- see Fig. 3 -RRB-	20978
an increase	20978
the H/M ratio	20993
Fig. 3	21012
The H/M ratio	21021
DM-injected animals	21062
4 months postlesion	21088
a plateau	21114
Fig. 1D	21137
contrast	21150
all animals of group OEC	21163
all animals	21163
group OEC	21178
the ratio H/M	21189
the first month	21227
transplantation	21249
the end of follow-up	21268
the end	21268
follow-up	21279
group DM	21326
the second month post-transplantation -LRB- Figs. 1D and 3 -RRB-	21340
the second month post-transplantation	21340
Figs. 1D and 3	21379
Figs. 1D	21379
3	21392
5 months after grafting	21399
5 months	21399
grafting	21414
the H/M ratio in groups OEC and DM	21424
the H/M ratio	21424
groups OEC and DM	21441
groups OEC	21441
DM	21456
319 6 29 % and 560 6 42 % , respectively -LRB- P < 0.001 -RRB-	21468
319 6 29 % and 560 6 42 % , respectively	21468
319 6 29 % and 560 6 42 %	21468
319 6 29 %	21468
319 6	21468
29 %	21474
560 6 42 %	21482
560 6	21482
42 %	21488
P < 0.001	21507
P	21507
< 0.001	21509
<	21509
0.001	21511
These results	21519
the view	21541
functional recovery observed in OEC transplanted rats	21555
functional recovery	21555
OEC transplanted rats	21587
the reestablishment of motor spinal pathways	21620
the reestablishment	21620
motor spinal pathways	21643
lumbar cord hyperreflexia	21680
Histological Results	21707
Fifteen days	21728
BDA injection -LRB- i.e. , 7 months postlesion -RRB-	21747
BDA injection	21747
regeneration of corticospinal -LRB- BDA labeled -RRB- and raphespinal -LRB- serotonergic -RRB- axons	21789
regeneration of corticospinal -LRB- BDA labeled -RRB-	21789
regeneration of corticospinal	21789
regeneration	21789
corticospinal	21805
BDA labeled	21820
BDA	21820
raphespinal -LRB- serotonergic -RRB- axons	21837
Fig. 4	21888
the cranial cord stump	21904
corticospinal axons	21927
the dorsal columns and fewer axons	21975
the dorsal columns	21975
fewer axons	21998
the ventral funiculi , whereas raphespinal axons were mainly observed in ventral and ventrolateral aspects of the spinal cord	22013
the ventral funiculi	22013
raphespinal axons	22043
ventral and ventrolateral aspects of the spinal cord	22085
ventral and ventrolateral aspects	22085
the spinal cord	22122
all animals	22142
both axonal populations	22155
the cranial edge stump	22198
they	22228
a branched morphology	22243
Animals receiving OEC grafts	22266
Animals	22266
OEC grafts	22284
slightly higher , though not significant , density of corticospinal and serotonergic axons	22302
slightly higher , though not significant , density	22302
corticospinal and serotonergic axons	22354
the cranial stump than DM-injected animals -LRB- Figs. 4E , F -RRB-	22394
the cranial stump	22394
DM-injected animals -LRB- Figs. 4E , F -RRB-	22417
DM-injected animals	22417
Figs. 4E , F	22438
Figs. 4E	22438
F	22447
group DM	22454
only a few axons	22464
the lesion epicenter	22498
none	22523
the caudal cord stump	22536
contrast	22562
all rats of group OEC	22575
all rats	22575
group OEC	22587
some corticospinal and raphespinal axons	22598
the lesion	22647
the caudal stump	22672
the gray matter	22696
the white matter	22724
Figs. 4B-D	22742
Significant higher density of corticospinal and of serotonergic axons	22755
higher density of corticospinal	22767
higher density	22767
OEC	22838
DM-injected rats in the lesion epicenter and caudal stump -LRB- Figs. 4E , F -RRB-	22851
DM-injected rats	22851
the lesion epicenter and caudal stump -LRB- Figs. 4E , F -RRB-	22871
the lesion epicenter and caudal stump	22871
Figs. 4E , F	22910
Figs. 4E	22910
F	22919
Most of the regenerating axons	22923
Most	22923
the regenerating axons	22931
the caudal edge stump	22973
some	23005
no corticospinal axons	23028
distances	23066
the gray matter	23084
low lumbar cord segments	23118
transverse sections made at L5	23147
transverse sections	23147
L5	23175
a few serotonergic axons	23179
the central , lateral , and ventral regions of the gray matter -LRB- laminae VIII and IX -RRB- -LRB- see Fig. 5 -RRB-	23222
the central , lateral , and ventral regions	23222
the gray matter -LRB- laminae VIII and IX -RRB- -LRB- see Fig. 5 -RRB-	23267
the gray matter -LRB- laminae VIII and IX -RRB-	23267
the gray matter	23267
laminae VIII and IX	23284
laminae VIII	23284
IX	23301
Fig. 5	23310
We	23319
transplantation of OECs into the chronically injured spinal cord	23343
transplantation	23343
OECs into the chronically injured spinal cord	23362
OECs	23362
the chronically injured spinal cord	23372
the posttraumatic astrogliosis	23435
means of GFAP immunohistochemistry	23469
means	23469
GFAP immunohistochemistry	23478
The density of GFAP immunoreactive processes	23505
The density	23505
GFAP immunoreactive processes	23520
the lesion margins	23567
the adjacent cord tissue	23593
the lesion site	23653
Quantitative analysis of GFAP immunoreactivity	23670
Quantitative analysis	23670
GFAP immunoreactivity	23695
there	23731
similar levels in both injured groups -LRB- P > 0.05 -RRB- -LRB- see Fig. 6 -RRB-	23742
similar levels	23742
both injured groups -LRB- P > 0.05 -RRB- -LRB- see Fig. 6 -RRB-	23760
both injured groups -LRB- P > 0.05 -RRB-	23760
both injured groups	23760
P > 0.05	23781
P	23781
> 0.05	23783
>	23783
0.05	23785
Fig. 6	23796
Survival of transplanted OECs	23805
Survival	23805
transplanted OECs	23817
means of p75 NTR staining -LRB- Resnick et al. , 2003 ; Garc ƒ ± a-Al ƒ ± as et al. , 2004 -RRB-	23852
means	23852
p75 NTR staining -LRB- Resnick et al. , 2003 ; Garc ƒ ± a-Al ƒ ± as et al. , 2004 -RRB-	23861
p75 NTR staining	23861
Resnick	23879
et al. , 2003 ; Garc ƒ ± a-Al ƒ ± as et al. , 2004	23887
et al.	23887
2003 ; Garc ƒ ± a-Al ƒ ± as et al.	23895
2003	23895
Garc ƒ ± a-Al ƒ ± as et al.	23901
Garc ƒ ± a-Al ƒ ±	23901
Garc ƒ	23901
a-Al ƒ ±	23908
et al.	23918
2004	23926
the possibility of falsepositive cells since Schwann cells that migrate into the injured spinal cord parenchyma also express p75 NTR	23941
the possibility	23941
falsepositive cells since Schwann cells	23960
falsepositive cells	23960
Schwann cells	23986
the injured spinal cord parenchyma also express p75 NTR	24018
the injured spinal cord parenchyma	24018
p75 NTR	24066
A few p75 positive cells	24075
A few p75	24075
positive cells	24085
regions of the cranial and caudal stumps close to the transection site	24114
regions	24114
the cranial and caudal stumps close to the transection site	24125
the cranial and caudal stumps	24125
the transection site	24164
distant levels	24196
DISCUSSION The present study	24213
DISCUSSION	24213
The present study	24224
OECs transplanted 45 days after complete transection of the spinal cord	24275
OECs	24275
45 days	24293
complete transection of the spinal cord	24307
complete transection	24307
the spinal cord	24331
axonal regeneration and functional recovery	24368
regeneration	24375
The results observed herein	24413
The results	24413
chronic OEC grafts	24458
partial restitution of supraspinal pathways , modest but significant recovery of hindlimb movements	24485
partial restitution	24485
supraspinal pathways , modest but significant recovery of hindlimb movements	24508
supraspinal pathways	24508
modest but significant recovery of hindlimb movements	24530
modest but significant recovery	24530
hindlimb movements	24565
hyperreflexia	24599
complete spinal cord injury	24619
Histologically , only animals transplanted with OECs presented corticospinal and raphespinal axons	24648
Histologically	24648
animals transplanted with OECs presented corticospinal and raphespinal axons	24669
animals	24669
OECs presented corticospinal and raphespinal axons	24695
OECs	24695
corticospinal and raphespinal axons	24710
the lesion	24756
serotonergic fibers	24772
lumbar cord segments	24812
delayed transplantation of OECs	24843
delayed transplantation	24843
OECs	24870
posttraumatic astrogliosis	24892
OEC transplants	24920
neuroprotection -LRB- Verd u et al. , 2001 , 2003 ; L opez-Vales et al. , 2004a -RRB- and axonal regeneration -LRB- Li et al. , 1998 ; Lu et al. , 2001 ; L opez-Vales et al. , 2006 ; Ramon-Cueto et al. , 2000 -RRB- when they are grafted acutely or shortly delayed after partial or complete spinal cord injuries , although there is some controversy in the literature -LRB- Resnick et al. , 2003 ; Takami et al. , 2002 -RRB-	24966
neuroprotection -LRB- Verd u et al. , 2001 , 2003 ; L opez-Vales et al. , 2004a -RRB-	24966
neuroprotection	24966
Verd u	24983
et al. , 2001 , 2003 ; L opez-Vales et al. , 2004a	24990
et al.	24990
2001 , 2003 ; L opez-Vales et al.	24998
2001 , 2003	24998
2001	24998
2003	25004
L opez-Vales et al.	25010
L opez-Vales	25010
et al.	25023
2004a	25031
axonal regeneration -LRB- Li et al. , 1998 ; Lu et al. , 2001 ; L opez-Vales et al. , 2006 ; Ramon-Cueto et al. , 2000 -RRB- when they are grafted acutely or shortly delayed after partial or complete spinal cord injuries , although there is some controversy in the literature -LRB- Resnick et al. , 2003 ; Takami et al. , 2002 -RRB-	25042
axonal regeneration	25042
Li et al. , 1998 ; Lu et al. , 2001 ; L opez-Vales et al. , 2006 ; Ramon-Cueto et al. , 2000	25063
Li	25063
et al. , 1998 ; Lu et al. , 2001 ; L opez-Vales et al. , 2006 ; Ramon-Cueto et al. , 2000	25066
et al. , 1998	25066
et al.	25066
1998	25074
Lu et al. , 2001	25080
Lu	25080
et al. , 2001	25083
et al.	25083
2001	25091
L opez-Vales et al. , 2006	25097
L opez-Vales	25097
et al. , 2006	25110
et al.	25110
2006	25118
Ramon-Cueto et al. , 2000	25124
Ramon-Cueto	25124
et al. , 2000	25136
et al.	25136
2000	25144
they	25155
partial or complete spinal cord injuries	25205
there	25256
some controversy in the literature -LRB- Resnick et al. , 2003 ; Takami et al. , 2002 -RRB-	25265
some controversy	25265
the literature -LRB- Resnick et al. , 2003 ; Takami et al. , 2002 -RRB-	25285
the literature	25285
Resnick	25301
et al. , 2003 ; Takami et al. , 2002	25309
et al.	25309
2003 ; Takami et al.	25317
2003	25317
Takami et al.	25323
Takami	25323
et al.	25330
2002	25338
This	25345
the first full report studying the effects of purified OECs when they are transplanted after a relatively long period , one month and a half , after complete spinal cord injury	25353
the first full report	25353
the effects of purified OECs	25384
the effects	25384
purified OECs	25399
they	25418
a relatively long period , one month and a half ,	25446
a relatively long period	25446
one month and a half	25472
one month	25472
a half	25486
complete spinal cord injury	25500
this	25539
the first work evaluating reestablishment of supraspinal pathways and changes in lumbar reflexes by electrophysiological techniques after chronic OEC grafts	25552
the first work	25552
reestablishment of supraspinal pathways and changes	25578
reestablishment	25578
supraspinal pathways and changes	25597
lumbar reflexes	25633
electrophysiological techniques	25652
chronic OEC grafts	25690
spinal cord transection	25716
MEPs	25741
all descending tracts	25764
time	25824
spontaneous axonal regeneration	25837
the nontransplanted spinal cord	25882
recovery of electrophysiological responses observed after OEC transplantation	25926
recovery	25926
electrophysiological responses observed after OEC transplantation	25938
electrophysiological responses	25938
OEC transplantation	25984
regrowth and caudal functional reconnection of a number of supraspinal axons that crossed the lesion site	26023
regrowth	26023
caudal functional reconnection of a number of supraspinal axons that crossed the lesion site	26036
caudal functional reconnection	26036
a number of supraspinal axons	26070
a number	26070
supraspinal axons	26082
the lesion site	26113
only the OEC-transplanted animals that recovered MEPs	26139
only the OEC-transplanted animals	26139
MEPs	26188
improvements in hindlimb movements	26208
improvements	26208
hindlimb movements	26224
These animals	26244
BBB values	26266
3 and 6	26285
BBB values of DM-injected and OEC-grafted rats without MEPs restitution	26302
BBB values	26302
DM-injected and OEC-grafted rats without MEPs restitution	26316
DM-injected and OEC-grafted rats	26316
MEPs restitution	26357
0 and 2	26389
These data	26398
functional recovery achieved in those animals	26423
functional recovery	26423
those animals	26455
partial return of descending control of hindlimb motoneurons	26480
partial return	26480
descending control of hindlimb motoneurons	26498
descending control	26498
hindlimb motoneurons	26520
We	26542
functional recovery	26562
changes in reflex circuit excitability	26593
changes	26593
reflex circuit excitability	26604
electrophysiological tests	26638
OEC grafts	26679
hyperreflexia	26698
agreement with behavioral and electrophysiological results	26716
agreement	26716
behavioral and electrophysiological results	26731
we	26776
delayed OEC grafts	26793
regeneration of corticospinal and raphespinal fibers	26821
regeneration	26821
corticospinal and raphespinal fibers	26837
the lesion level	26880
Long distance axonal regeneration of raphespinal , but not corticospinal , fibers reaching lumbar segments of the spinal cord	26898
Long distance axonal regeneration	26898
raphespinal , but not corticospinal , fibers reaching lumbar segments of the spinal cord	26935
raphespinal , but not corticospinal , fibers	26935
lumbar segments of the spinal cord	26987
lumbar segments	26987
the spinal cord	27006
those transplanted animals that recovered MEPs	27043
those transplanted animals	27043
MEPs	27085
Serotonergic axons	27091
an important role	27137
recovery of locomotion	27158
recovery	27158
locomotion	27170
the modulation of hyperreflexia	27188
the modulation	27188
hyperreflexia	27206
spinal cord injury -LRB- Ribotta et al. , 1998 , 2000 -RRB-	27226
spinal cord injury	27226
Ribotta	27246
et al. , 1998 , 2000	27254
et al.	27254
1998	27262
2000	27268
our results	27284
OECs	27309
the caudal cord excitability	27335
axonal regeneration	27381
a reduced H/M ratio	27408
the first month	27452
MEPs	27489
OECtransplanted animals	27530
MEPs	27563
comparison with acute or 1 week delayed OEC transplants that we recently reported using the same experimental model and techniques -LRB- L opez-Vales et al. , 2006 -RRB-	27588
comparison with acute	27588
comparison	27588
1 week delayed OEC transplants that we recently reported using the same experimental model and techniques -LRB- L opez-Vales et al. , 2006 -RRB-	27613
1 week	27613
OEC transplants	27628
we	27649
the same experimental model and techniques -LRB- L opez-Vales et al. , 2006 -RRB-	27676
the same experimental model	27676
techniques -LRB- L opez-Vales et al. , 2006 -RRB-	27708
techniques	27708
L opez-Vales et al. , 2006	27720
L opez-Vales	27720
et al.	27733
2006	27741
we	27748
chronic OEC transplant	27762
lower degree of functional restoration	27793
lower degree	27793
functional restoration	27809
at 5 months after transplantation the BBB score achieved in acutely , 7 and 45 days delayed OEC grafted rats that recovered MEPs	27848
at 5 months after transplantation the BBB score achieved in acutely , 7 and 45 days delayed OEC grafted rats	27848
5 months	27851
transplantation	27866
the BBB score achieved in acutely	27882
the BBB score	27882
7 and 45 days delayed OEC grafted rats	27917
7 and 45 days	27917
OEC grafted rats	27939
OEC	27939
rats	27951
MEPs	27971
5.0 ± 0.5 , 3.9 ± 0.3 , and 3.8 ± 0.5	27980
5.0 ± 0.5	27980
5.0	27980
0.5	27986
3.9 ± 0.3	27991
3.9 ±	27991
0.3	27997
3.8 ± 0.5	28006
3.8	28006
0.5	28012
A similar pattern	28031
MEP recordings	28066
the amplitude of MEPs	28082
the amplitude	28082
MEPs	28099
mean values of 886 ± 380 , 310 ± 111 , and 249 ± 80 µV	28113
mean values	28113
886 ± 380 , 310 ± 111 , and 249 ± 80 µV	28128
886 ± 380	28128
886 ±	28128
380	28134
310 ± 111	28139
310 ±	28139
111	28145
249 ± 80 µV	28154
249	28154
80 µV	28160
acute , 7 and 45 days delayed OEC transplanted animals , respectively	28169
acute	28169
7 and 45 days delayed OEC transplanted animals , respectively	28176
7 and 45 days	28176
OEC	28198
transplanted animals	28202
These results	28238
evidence that OEC grafts	28260
evidence	28260
OEC grafts	28274
their effectiveness	28304
spinal cord restoration	28337
increasing delay between injury and transplantation	28366
increasing delay	28366
injury and transplantation	28391
the other hand	28422
the time of transplantation	28438
the time	28438
transplantation	28450
the percentage of animals that successfully recovered MEPs and hindlimb movements , which was 60 % in each of these three OEC transplanted groups	28490
the percentage	28490
animals that successfully recovered MEPs and hindlimb movements , which was 60 % in each of these three OEC transplanted groups	28508
animals	28508
MEPs and hindlimb movements , which was 60 % in each of these three OEC transplanted groups	28544
MEPs and hindlimb movements	28544
60 %	28583
each of these three OEC	28590
each	28590
these three OEC	28598
transplanted groups	28614
the search for mechanisms	28638
the search	28638
mechanisms	28653
the neuroregenerative properties of OEC grafts	28675
the neuroregenerative properties	28675
OEC grafts	28711
we	28723
OECs	28742
the reactivity of astrocytes	28769
the reactivity	28769
astrocytes	28787
results	28813
acute and 1 week delayed OEC transplants -LRB- L opez-Vales et al. , 2006 -RRB-	28827
acute	28827
1 week delayed OEC transplants -LRB- L opez-Vales et al. , 2006 -RRB-	28837
1 week	28837
OEC transplants -LRB- L opez-Vales et al. , 2006 -RRB-	28852
OEC transplants	28852
L opez-Vales et al. , 2006	28869
L opez-Vales	28869
et al.	28882
2006	28890
chronic OEC transplants	28897
astrogliosis	28938
It	28952
hypertrophy of astrocytes and expression of proteoglycans	28969
hypertrophy	28969
astrocytes and expression	28984
proteoglycans	29013
a maximal peak	29033
2 weeks after injury -LRB- Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2004b ; Tang et al. , 2003 -RRB-	29051
2 weeks	29051
injury -LRB- Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2004b ; Tang et al. , 2003 -RRB-	29065
injury	29065
Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2004b ; Tang et al. , 2003	29073
Garc ƒ	29073
± a-Al ƒ ± as et al. , 2004 ; L opez-Vales et al. , 2004b ; Tang et al. , 2003	29079
± a-Al ƒ ± as et al. , 2004	29079
± a-Al ƒ ±	29079
et al. , 2004	29090
et al.	29090
2004	29098
L opez-Vales et al. , 2004b	29104
L opez-Vales	29104
et al. , 2004b	29117
et al.	29117
2004b	29125
Tang et al. , 2003	29132
Tang	29132
et al. , 2003	29137
et al.	29137
2003	29145
45 days	29163
time	29191
OEC transplants	29200
astrogliosis and proteoglycan expression	29226
rat spinal cord injury	29273
part , the lower functional results obtained in comparison with those observed after acute or 1 week delayed transplants	29317
part	29317
the lower functional results obtained in comparison with those observed after acute or 1 week delayed transplants	29323
the lower functional results	29323
comparison	29364
those observed after acute or 1 week delayed transplants	29380
those	29380
acute or 1 week delayed transplants	29401
or 1 week	29407
Keyvan-Fouladi et al. -LRB- 2003 -RRB-	29438
Keyvan-Fouladi et al.	29438
Keyvan-Fouladi	29438
et al.	29453
2003	29461
OECs	29480
an unilateral corticospinal electrolytic lesion 2 months	29490
an unilateral corticospinal electrolytic lesion	29490
2 months	29538
the initial injury	29553
OEC grafts	29591
corticospinal axonal regeneration and functional recovery	29611
axonal regeneration	29625
comparison with results shown in a previous study on acute OEC grafts using the same injury model -LRB- Li et al. , 1998 -RRB-	29673
comparison	29673
results shown in a previous study on acute OEC grafts using the same injury model -LRB- Li et al. , 1998 -RRB-	29689
results	29689
a previous study on acute OEC grafts	29706
a previous study	29706
acute OEC grafts	29726
the same injury model -LRB- Li et al. , 1998 -RRB-	29749
the same injury model	29749
Li	29772
et al. , 1998	29775
et al.	29775
1998	29783
delayed transplants	29790
better functional results -LRB- Keyvan-Fouladi et al. , 2003 -RRB-	29819
better functional results	29819
Keyvan-Fouladi	29846
et al. , 2003	29861
et al.	29861
2003	29869
The differences	29876
the proportion of rats recovering forepaw function , and not in quantitative analyses	29921
the proportion	29921
rats recovering forepaw function , and not in quantitative analyses	29939
rats	29939
forepaw function	29955
quantitative analyses	29984
functional recovery after unilateral corticospinal injury	30017
functional recovery	30017
unilateral corticospinal injury	30043
contralateral or ventral ipsilateral corticospinal fibers , which are spared after injury -LRB- Steward et al. , 2003 -RRB-	30107
contralateral or ventral ipsilateral corticospinal fibers	30107
injury -LRB- Steward et al. , 2003 -RRB-	30189
injury	30189
Steward	30197
et al. , 2003	30205
et al.	30205
2003	30213
We	30220
a complete transection of the spinal cord	30229
a complete transection	30229
the spinal cord	30255
the injury model for two reasons	30274
the injury model	30274
two reasons	30295
the presence of supraspinal axons below the lesion site	30315
the presence	30315
supraspinal axons below the lesion site	30331
supraspinal axons	30331
the lesion site	30355
axonal regeneration	30395
all spinal cord pathways	30423
the injury	30467
complete spinal cord transection represents a severe injury , and results obtained in this experimental model	30487
complete spinal cord transection	30487
a severe injury	30531
this experimental model	30572
milder injuries	30623
There	30640
two previous works	30655
comparable delayed OEC grafts after spinal cord transection -LRB- Lu et al. , 2002 ; Steward et al. , 2006 -RRB- reporting controversial results	30687
comparable delayed OEC grafts	30687
spinal cord transection -LRB- Lu et al. , 2002 ; Steward et al. , 2006 -RRB- reporting controversial results	30723
spinal cord transection -LRB- Lu et al. , 2002 ; Steward et al. , 2006 -RRB-	30723
spinal cord transection	30723
Lu	30748
et al. , 2002 ; Steward et al. , 2006	30751
et al.	30751
2002 ; Steward et al.	30759
2002	30759
Steward et al.	30765
Steward	30765
et al.	30773
2006	30781
controversial results	30797
Lu et al. -LRB- 2002 -RRB-	30820
Lu et al.	30820
Lu	30820
et al.	30823
2002	30831
olfactory mucosa	30845
1 month	30862
injury	30876
such grafts	30899
regeneration of serotonergic axons	30920
regeneration	30920
serotonergic axons	30936
a maximal outgrowth distance of 4 mm caudal to the graft , and slight recovery of hindlimb movements	30960
a maximal outgrowth distance	30960
4 mm caudal to the graft , and slight recovery of hindlimb movements	30992
4 mm caudal to the graft	30992
4 mm caudal	30992
the graft	31007
slight recovery of hindlimb movements	31022
slight recovery	31022
hindlimb movements	31041
BBB values after delayed olfactory mucosa grafts	31070
BBB values	31070
delayed olfactory mucosa grafts	31087
1 and 6 points -LRB- Lu et al. , 2002 -RRB-	31124
1 and 6 points	31124
Lu	31140
et al. , 2002	31143
et al.	31143
2002	31151
contrast with scores between 6 and 8 reported by the same group in rats acutely transplanted -LRB- Lu et al. , 2001 -RRB-	31161
contrast	31161
scores between 6 and 8	31175
scores	31175
6 and 8	31190
the same group in rats acutely transplanted -LRB- Lu et al. , 2001 -RRB-	31210
the same group	31210
rats acutely transplanted	31228
rats	31228
Lu	31255
et al. , 2001	31258
et al.	31258
2001	31266
a recent replicate of those experiments	31287
a recent	31287
those experiments	31309
successful results -LRB- Steward et al. , 2006 -RRB-	31349
successful results	31349
Steward	31369
et al. , 2006	31377
et al.	31377
2006	31385
It	31392
account that olfactory mucosa tissue contains not only OECs but also Schwann cells and other types of cells such as fibroblasts	31416
account	31416
olfactory mucosa tissue	31429
not only OECs but also Schwann cells and other types of cells such as fibroblasts	31462
OECs	31471
Schwann cells and other types of cells such as fibroblasts	31485
Schwann cells	31485
other types of cells such as fibroblasts	31503
other types	31503
cells such as fibroblasts	31518
cells	31518
fibroblasts	31532
Schwann cells	31545
hypertrophy of astrocytes and proteoglycan synthesis -LRB- Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; Lakatos et al. , 2000 -RRB-	31589
hypertrophy	31589
astrocytes and proteoglycan synthesis	31604
Garc ƒ ± a-Al ƒ ± as et al. , 2004 ; Lakatos et al. , 2000	31643
Garc ƒ	31643
± a-Al ƒ ± as et al. , 2004 ; Lakatos et al. , 2000	31649
± a-Al ƒ ± as et al. , 2004	31649
± a-Al ƒ ±	31649
et al. , 2004	31660
et al.	31660
2004	31668
Lakatos et al. , 2000	31674
Lakatos	31674
et al. , 2000	31682
et al.	31682
2000	31690
fibroblasts	31705
semaphorin-3 , a well known inhibitor of axonal regeneration -LRB- Koeberle and B ` Ç ¨ ahr , 2004 -RRB-	31725
semaphorin-3	31725
a well known inhibitor of axonal regeneration -LRB- Koeberle and B ` Ç ¨ ahr , 2004 -RRB-	31739
a well known inhibitor	31739
axonal regeneration -LRB- Koeberle and B ` Ç ¨ ahr , 2004 -RRB-	31765
axonal regeneration	31765
Koeberle and B ` Ç ¨ ahr , 2004	31786
Koeberle and B ` Ç ¨ ahr	31786
2004	31808
it	31823
Schwann cells and fibroblasts from the olfactory mucosa	31845
Schwann cells and fibroblasts	31845
the olfactory mucosa	31880
the restorative properties of OECs	31939
the restorative properties	31939
OECs	31969
acute purified	32015
acute	32015
OEC transplants	32030
acute olfactory mucosa grafts	32079
functional recovery	32122
complete transection of the spinal cord -LRB- Lu et al. , 2001 -RRB-	32148
complete transection	32148
the spinal cord -LRB- Lu et al. , 2001 -RRB-	32172
the spinal cord	32172
Lu	32189
et al. , 2001	32192
et al.	32192
2001	32200
we	32207
OECs	32236
the olfactory bulb for transplants	32246
the olfactory bulb	32246
transplants	32269
We	32282
the survival of transplanted cells by means of the OEC expression of p75NTR	32298
the survival	32298
transplanted cells by means of the OEC expression of p75NTR	32314
transplanted cells	32314
means of the OEC expression of p75NTR	32336
means	32336
the OEC expression of p75NTR	32345
the OEC expression	32345
p75NTR	32367
the large number of cells grafted in this experiment , only very few p75	32383
the large number	32383
cells grafted in this experiment , only very few p75	32403
cells	32403
this experiment , only very few p75	32420
this experiment	32420
few p75	32447
positive cells	32455
5 months	32481
The absence of p75 labeled cells	32506
The absence	32506
p75 labeled cells	32521
p75	32521
cells	32533
the death of the transplanted cells	32576
the death	32576
the transplanted cells	32589
OECs	32619
their expression of p75	32637
their expression	32637
p75	32657
they	32666
axons -LRB- Wewetzer et al. , 2005 -RRB-	32691
axons	32691
Wewetzer	32698
et al. , 2005	32707
et al.	32707
2005	32715
conclusion	32725
this	32737
the first report demonstrating that transplantation of OECs 45 days after spinal cord transection promotes axonal regeneration , reestablishment of supraspinal pathways and moderate , though significant , functional recovery	32745
the first report	32745
transplantation of OECs 45 days after spinal cord transection	32781
transplantation	32781
OECs 45 days after spinal cord transection	32800
OECs	32800
45 days	32805
spinal cord transection	32819
axonal regeneration , reestablishment of supraspinal pathways and moderate , though significant , functional recovery	32852
axonal regeneration	32852
reestablishment of supraspinal pathways	32873
reestablishment	32873
supraspinal pathways	32892
moderate , though significant , functional recovery	32917
functional and histological results	32977
those obtained previously with acute	33029
those	33029
1 week delayed OEC transplants -LRB- L opez-Vales et al. , 2006 -RRB-	33069
1 week	33069
OEC transplants -LRB- L opez-Vales et al. , 2006 -RRB-	33084
OEC transplants	33084
L opez-Vales et al. , 2006	33101
L opez-Vales	33101
et al.	33114
2006	33122
These data	33129
the efficacy of transplanted cells	33153
the efficacy	33153
transplanted cells	33169
the timing	33199
the injury	33216
cells	33254
injury	33291
the fact that long delayed OEC transplants also allowed for partial repair after complete spinal cord injury	33313
the fact	33313
OEC transplants	33340
partial repair	33373
complete spinal cord injury	33394
an important step towards the use of OECs as a treatment for chronic spinal cord injuries in humans	33431
an important step	33431
the use of OECs as a treatment for chronic spinal cord injuries in humans	33457
the use	33457
OECs as a treatment for chronic spinal cord injuries in humans	33468
OECs	33468
a treatment for chronic spinal cord injuries in humans	33476
a treatment	33476
chronic spinal cord injuries in humans	33492
chronic spinal cord injuries	33492
humans	33524
